EFTA00675936Set 9
2013-11-122p697w
laboratory space and GMP
manufacturing in compliance with FDA and ISO 13485 standards.
*MMWR Weekly Report "Vital Signs: Preventing Clostridium difficile Infections" March 9, 2012 / 61(09); 157-
162
EFTA00675936
https://www.justice.gov/epstein/files/DataSet%209/EFTA00675936.pdf